Sorry, this article is only available in French.
A press review is only a summary of media analysis and press articles that have been read to realize it each day. The press review can not be interpreted as reflecting the point of view of Inserm. The link towards the original article, when existing, is indicated in the synthesis.
These links, active at the updating date, may become unavailable in the following days. This depends on the media policy.
Microdystrophin restores muscle strength in Duchenne muscular dystrophy
Yves Lévy, Chairman and CEO of Inserm, appointed member of the UN “Global Health Crises” Task Force
(Français) Thérapie génique : des premiers résultats chez des enfants atteints de la maladie de Sanfilippo B
Epstein-Barr virus and cancer: new tricks from an old dog